Insider trades
Birgit C. Schultes, Chief Officer of Intellia Therapeutics NTLA, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $78.9K. The latest trade was on 03/01.
Birgit C. Schultes
EVP, Chief Scientific Officer
- Company
- Intellia Therapeutics NTLA
- First filing
- 25/03/04
- Trades
- 6 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- −$78.9K
- Last trade
- 03/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/05 | 01/07 | 8,508 sh | $9.21 | $78,358.68 | −7.9% | |
| Open-market sale | 25/10/01 | 25/10/03 | 31 sh | $17.38 | $538.78 | −0.0% |